相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab Post Hoc Review of HAWK and HARRIER
Jordi Mones et al.
OPHTHALMOLOGY (2021)
Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review
William J. Anderson et al.
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS (2021)
Macular Atrophy in Neovascular Age-Related Macular Degeneration A Randomized Clinical Trial Comparing Ranibizumab and Aflibercept (RIVAL Study)
Mark C. Gillies et al.
OPHTHALMOLOGY (2020)
Comparison of the Efficacy of Brolucizumab with Natural Disease Progression in Wet AMD Using Clinical Data from the Phase III HAWK and HARRIER Trials and Modelled Placebo Data
Hansjuergen Agostini et al.
CURRENT EYE RESEARCH (2020)
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Caroline R. Baumal et al.
OPHTHALMOLOGY (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Effectiveness of monthly and fortnightly anti-VEGF treatments for age-related macular degeneration
Renata Portella Nunes et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2019)
Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
Nicolas A. Yannuzzi et al.
CLINICAL OPHTHALMOLOGY (2019)
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials
Chu Luan Nguyen et al.
BMC OPHTHALMOLOGY (2018)
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
Pravin U. Dugel et al.
OPHTHALMOLOGY (2017)
Ranibizumab or Bevacizumab for Neovascular Age-Related Macular Degeneration According to the Lucentis Compared to Avastin Study Treat-and-Extend Protocol Two-Year Results
Karina Berg et al.
OPHTHALMOLOGY (2016)
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
Frank G. Holz et al.
OPHTHALMOLOGY (2016)
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ninety-Six-Week Results of the VIEW Studies
Ursula Schmidt-Erfurth et al.
OPHTHALMOLOGY (2014)
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
Ilse Krebs et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
Usha Chakravarthy et al.
LANCET (2013)
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
Laurent Kodjikian et al.
OPHTHALMOLOGY (2013)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Comparative role of intravitreal ranibizumab versus bevacizumab in choroidal neovascular membrane in age-related macular degeneration
Partha Biswas et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2011)
Bevacizumab vs ranibizumab for age-related macular degeneration: 1-year outcomes of a prospective, double-masked randomised clinical trial
M. L. Subramanian et al.
EYE (2010)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
分享论文
